MicroRNAs in Cardiovascular Therapeutics

Current Topics in Medicinal Chemistry

Volumn 13, Issue 13, 2013, Pages 1605-1618

  Siasos, Gerasimos ^a   Tousoulis, Dimitris ^a   Tourikis, Panagiotis ^a   Mazaris, Savas ^a   Zakynthinos, Giorgos ^a   Oikonomou, Evangelos ^a   Kokkou, Eleni ^a   Kollia, Christina ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Atherosclerosis; Cardiovascular disease; MicroRNAs; Therapy

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 124; MICRORNA 124A; MICRORNA 133; MICRORNA 135A; MICRORNA 155; MICRORNA 195; MICRORNA 199B; MICRORNA 200A; MICRORNA 200B; MICRORNA 208A; MICRORNA 21; MICRORNA 210; MICRORNA 24; MICRORNA 27B; MICRORNA 292; MICRORNA 298; MICRORNA 29B; MICRORNA 320; MICRORNA 34A; MICRORNA 375; MICRORNA 429; MICRORNA 494; MICRORNA 497; MICRORNA 9; MICRORNA 92A; MICRORNA 96; TROPONIN; UNCLASSIFIED DRUG;

APOPTOSIS; BIOGENESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MICRORNAS;

EID: 84881327509     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/15680266113139990109     Document Type: Review

References (140)

1. Ambros, V. The functions of animal microRNAs. Nature, 2004, 431(7006), 350-355.
2. Lai, E. C. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet., 2002, 30(4), 363-364.
3. Gschwend, A. R.; Weingartner, L. A.; Moore, R. C.; Ming, R. The sex-specific region of sex chromosomes in animals and plants. Chromosome Res., 2012, 20(1), 57-69.
4. Yin, Z.; Li, C.; Han, X.; Shen, F. Identification of conserved microRNAs and their target genes in tomato (Lycopersicon esculentum). Gene, 2008, 414(1-2), 60-66.
5. Dhandapani, V.; Ramchiary, N.; Paul, P.; Kim, J.; Choi, S. H.; Lee, J.; Hur, Y.; Lim, Y. P. Identification of potential microRNAs and their targets in Brassica rapa L. Mol. Cells, 2011, 32(1), 21-37.
6. Sibley, C. R.; Seow, Y.; Saayman, S.; Dijkstra, K. K.; El Andaloussi, S.; Weinberg, M. S.; Wood, M. J. The biogenesis and characterization of mammalian microRNAs of mirtron origin. Nucleic Acids Res., 2012, 40(1), 438-448.
7. Granjon, A.; Gustin, M. P.; Rieusset, J.; Lefai, E.; Meugnier, E.; Guller, I.; Cerutti, C.; Paultre, C.; Disse, E.; Rabasa-Lhoret, R.; Laville, M.; Vidal, H.; Rome, S. The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway. Diabetes, 2009, 58(11), 2555-2564.
8. Zhao, Y.; Samal, E.; Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 2005, 436(7048), 214-220.
9. Zampetaki, A.; Mayr, M. MicroRNAs in vascular and metabolic disease. Circ. Res., 2012, 110(3), 508-522.
10. Thum, T. MicroRNA therapeutics in cardiovascular medicine. EMBO Mol. Med., 2012, 4(1), 3-14.
11. Papageorgiou, N.; Tousoulis, D.; Androulakis, E.; Siasos, G.; Briasoulis, A.; Vogiatzi, G.; Kampoli, A. M.; Tsiamis, E.; Tentolouris, C.; Stefanadis, C. The role of microRNAs in cardiovascular disease. Curr. Med. Chem., 2012, 19(16), 2605-2610.
12. Care, A.; Catalucci, D.; Felicetti, F.; Bonci, D.; Addario, A.; Gallo, P.; Bang, M. L.; Segnalini, P.; Gu, Y.; Dalton, N. D.; Elia, L.; Latronico, M. V.; Hoydal, M.; Autore, C.; Russo, M. A.; Dorn, G. W. 2nd; Ellingsen, O.; Ruiz-Lozano, P.; Peterson, K. L.; Croce, C. M.; Peschle, C.; Condorelli, G. MicroRNA-133 controls cardiac hypertrophy. Nat. Med., 2007, 13(5), 613-618.
13. Schroen, B.; Heymans, S. MicroRNAs and beyond: the heart reveals its treasures. Hypertension, 2009, 54(6), 1189-1194.
14. Thum, T.; Galuppo, P.; Wolf, C.; Fiedler, J.; Kneitz, S.; van Laake, L. W.; Doevendans, P. A.; Mummery, C. L.; Borlak, J.; Haverich, A.; Gross, C.; Engelhardt, S.; Ertl, G.; Bauersachs, J. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation, 2007, 116(3), 258-267.
15. van Rooij, E.; Sutherland, L. B.; Liu, N.; Williams, A. H.; McAnally, J.; Gerard, R. D.; Richardson, J. A.; Olson, E. N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A, 2006, 103(48), 18255-18260.
16. Starega-Roslan, J.; Koscianska, E.; Kozlowski, P.; Krzyzosiak, W. J. The role of the precursor structure in the biogenesis of microRNA. Cell Mol Life Sci, 2011, 68(17), 2859-2871.
17. Han, J.; Lee, Y.; Yeom, K. H.; Kim, Y. K.; Jin, H.; Kim, V. N. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev, 2004, 18(24), 3016-3027.
18. Yi, R.; Qin, Y.; Macara, I. G.; Cullen, B. R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev., 2003, 17(24), 3011-3016.
19. Wang, X.; Xu, X.; Ma, Z.; Huo, Y.; Xiao, Z.; Li, Y.; Wang, Y. Dynamic mechanisms for pre-miRNA binding and export by Exportin-5. RNA, 2011, 17(8), 1511-1528.
20. Park, J. E.; Heo, I.; Tian, Y.; Simanshu, D. K.; Chang, H.; Jee, D.; Patel, D. J.; Kim, V. N. Dicer recognizes the 5' end of RNA for efficient and accurate processing. Nature, 2011, 475(7355), 201-205.
21. Gregory, R. I.; Chendrimada, T. P.; Cooch, N.; Shiekhattar, R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell, 2005, 123(4), 631-640.
22. Rotllan, N.; Fernandez-Hernando, C. MicroRNA Regulation of Cholesterol Metabolism. Cholesterol, 2012, 2012, 847849.
23. Sen, G. L.; Wehrman, T. S.; Blau, H. M. mRNA translation is not a prerequisite for small interfering RNA-mediated mRNA cleavage. Differentiation, 2005, 73(6), 287-293.
24. Davison, T. S.; Johnson, C. D.; Andruss, B. F. Analyzing micro-RNA expression using microarrays. Methods Enzymol., 2006, 411, 14-34.
25. Ikeda, S.; Kong, S. W.; Lu, J.; Bisping, E.; Zhang, H.; Allen, P. D.; Golub, T. R.; Pieske, B.; Pu, W. T. Altered microRNA expression in human heart disease. Physiol. Genomics, 2007, 31(3), 367-373.
26. Ambros, V.; Bartel, B.; Bartel, D. P.; Burge, C. B.; Carrington, J. C.; Chen, X.; Dreyfuss, G.; Eddy, S. R.; Griffiths-Jones, S.; Marshall, M.; Matzke, M.; Ruvkun, G.; Tuschl, T. A uniform system for microRNA annotation. RNA, 2003, 9(3), 277-279.
27. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K. G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature, 2005, 438(7068), 685-689.
28. Elmen, J.; Lindow, M.; Silahtaroglu, A.; Bak, M.; Christensen, M.; Lind-Thomsen, A.; Hedtjarn, M.; Hansen, J. B.; Hansen, H. F.; Straarup, E. M.; McCullagh, K.; Kearney, P.; Kauppinen, S. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res., 2008, 36(4), 1153-1162.
29. Patrick, D. M.; Montgomery, R. L.; Qi, X.; Obad, S.; Kauppinen, S.; Hill, J. A.; van Rooij, E.; Olson, E. N. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest., 2010, 120(11), 3912-3916.
30. Wang, Z. The concept of multiple-target anti-miRNA antisense oligonucleotide technology. Methods Mol. Biol., 2011, 676, 51-57.
31. van Rooij, E.; Sutherland, L. B.; Thatcher, J. E.; DiMaio, J. M.; Naseem, R. H.; Marshall, W. S.; Hill, J. A.; Olson, E. N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(35), 13027-13032.
32. Hinkel, R.; Trenkwalder, T.; Kupatt, C. Gene therapy for ischemic heart disease. Expert Opin. Biol. Ther., 2011, 11(6), 723-737.
33. Montgomery, R. L.; Hullinger, T. G.; Semus, H. M.; Dickinson, B. A.; Seto, A. G.; Lynch, J. M.; Stack, C.; Latimer, P. A.; Olson, E. N.; van Rooij, E. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation, 2011, 124(14), 1537-1547.
34. da Costa Martins, P. A.; Salic, K.; Gladka, M. M.; Armand, A. S.; Leptidis, S.; el Azzouzi, H.; Hansen, A.; Coenen-de Roo, C. J.; Bierhuizen, M. F.; van der Nagel, R.; van Kuik, J.; de Weger, R.; de Bruin, A.; Condorelli, G.; Arbones, M. L.; Eschenhagen, T.; De Windt, L. J. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat. Cell Biol., 2010, 12(12), 1220-1227.
35. Thum, T.; Gross, C.; Fiedler, J.; Fischer, T.; Kissler, S.; Bussen, M.; Galuppo, P.; Just, S.; Rottbauer, W.; Frantz, S.; Castoldi, M.; Soutschek, J.; Koteliansky, V.; Rosenwald, A.; Basson, M. A.; Licht, J. D.; Pena, J. T.; Rouhanifard, S. H.; Muckenthaler, M. U.; Tuschl, T.; Martin, G. R.; Bauersachs, J.; Engelhardt, S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 2008, 456(7224), 980-984.
36. Yin, K. J.; Deng, Z.; Huang, H.; Hamblin, M.; Xie, C.; Zhang, J.; Chen, Y. E. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol. Dis., 2010, 38(1), 17-26.
37. Liu, D. Z.; Tian, Y.; Ander, B. P.; Xu, H.; Stamova, B. S.; Zhan, X.; Turner, R. J.; Jickling, G.; Sharp, F. R. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab., 2010, 30(1), 92-101.
38. Jeyaseelan, K.; Lim, K. Y.; Armugam, A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke, 2008, 39(3), 959-966.
39. Lee, S. T.; Chu, K.; Jung, K. H.; Yoon, H. J.; Jeon, D.; Kang, K. M.; Park, K. H.; Bae, E. K.; Kim, M.; Lee, S. K.; Roh, J. K. MicroRNAs induced during ischemic preconditioning. Stroke, 2010, 41(8), 1646-1651.
40. Li, Y.; Xu, X.; Liang, Y.; Liu, S.; Xiao, H.; Li, F.; Cheng, H.; Fu, Z. miR-375 enhances palmitate-induced lipoapoptosis in insulinsecreting NIT-1 cells by repressing myotrophin (V1) protein expression. Int. J. Clin. Exp. Pathol., 2010, 3(3), 254-264.
41. Lovis, P.; Gattesco, S.; Regazzi, R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol. Chem., 2008, 389(3), 305-312.
42. Plaisance, V.; Abderrahmani, A.; Perret-Menoud, V.; Jacquemin, P.; Lemaigre, F.; Regazzi, R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulinproducing cells. J. Biol. Chem., 2006, 281(37), 26932-26942.
43. Karbiener, M.; Fischer, C.; Nowitsch, S.; Opriessnig, P.; Papak, C.; Ailhaud, G.; Dani, C.; Amri, E. Z.; Scheideler, M. microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem. Biophys. Res. Commun., 2009, 390(2), 247-251.
44. Tang, Y.; Zheng, J.; Sun, Y.; Wu, Z.; Liu, Z.; Huang, G. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int. Heart J., 2009, 50(3), 377-387.
45. Xu, C.; Lu, Y.; Pan, Z.; Chu, W.; Luo, X.; Lin, H.; Xiao, J.; Shan, H.; Wang, Z.; Yang, B. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J. Cell Sci., 2007, 120(Pt 17), 3045-3052.
46. Terentyev, D.; Belevych, A. E.; Terentyeva, R.; Martin, M. M.; Malana, G. E.; Kuhn, D. E.; Abdellatif, M.; Feldman, D. S.; Elton, T. S.; Gyorke, S. miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ. Res., 2009, 104(4), 514-521.
47. Matkovich, S. J.; Wang, W.; Tu, Y.; Eschenbacher, W. H.; Dorn, L. E.; Condorelli, G.; Diwan, A.; Nerbonne, J. M.; Dorn, G. W. 2nd MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ. Res., 2010, 106(1), 166-175.
48. Cheng, Y.; Liu, X.; Zhang, S.; Lin, Y.; Yang, J.; Zhang, C. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J. Mol. Cell Cardiol., 2009, 47(1), 5-14.
49. Yin, C.; Wang, X.; Kukreja, R. C. Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice. FEBS Lett., 2008, 582(30), 4137-4142.
50. Fiedler, J.; Jazbutyte, V.; Kirchmaier, B. C.; Gupta, S. K.; Lorenzen, J.; Hartmann, D.; Galuppo, P.; Kneitz, S.; Pena, J. T.; Sohn-Lee, C.; Loyer, X.; Soutschek, J.; Brand, T.; Tuschl, T.; Heineke, J.; Martin, U.; Schulte-Merker, S.; Ertl, G.; Engelhardt, S.; Bauersachs, J.; Thum, T. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation, 2011, 124(6), 720-730.
51. Qian, L.; Van Laake, L. W.; Huang, Y.; Liu, S.; Wendland, M. F.; Srivastava, D. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med., 2011, 208(3), 549-560.
52. Wang, X.; Zhang, X.; Ren, X. P.; Chen, J.; Liu, H.; Yang, J.; Medvedovic, M.; Hu, Z.; Fan, G. C. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation, 2010, 122(13), 1308-1318.
53. Hu, S.; Huang, M.; Li, Z.; Jia, F.; Ghosh, Z.; Lijkwan, M. A.; Fasanaro, P.; Sun, N.; Wang, X.; Martelli, F.; Robbins, R. C.; Wu, J. C. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation, 2010, 122(11 Suppl), S124-131.
54. Ren, X. P.; Wu, J.; Wang, X.; Sartor, M. A.; Qian, J.; Jones, K.; Nicolaou, P.; Pritchard, T. J.; Fan, G. C. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation, 2009, 119(17), 2357-2366.
55. Bonauer, A.; Carmona, G.; Iwasaki, M.; Mione, M.; Koyanagi, M.; Fischer, A.; Burchfield, J.; Fox, H.; Doebele, C.; Ohtani, K.; Chavakis, E.; Potente, M.; Tjwa, M.; Urbich, C.; Zeiher, A. M.; Dimmeler, S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science, 2009, 324(5935), 1710-1713.
56. Sun, H. X.; Zeng, D. Y.; Li, R. T.; Pang, R. P.; Yang, H.; Hu, Y. L.; Zhang, Q.; Jiang, Y.; Huang, L. Y.; Tang, Y. B.; Yan, G. J.; Zhou, J. G. Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension, 2012, 60(6), 1407-1414.
57. Wang, K.; Long, B.; Zhou, J.; Li, P. F. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J. Biol. Chem., 2010, 285(16), 11903-11912.
58. Sober, S.; Laan, M.; Annilo, T. MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression. Biochem. Biophys. Res. Commun., 2010, 391(1), 727-732.
59. Adam, O.; Lohfelm, B.; Thum, T.; Gupta, S. K.; Puhl, S. L.; Schafers, H. J.; Bohm, M.; Laufs, U. Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res. Cardiol., 2012, 107(5), 278.
60. White, H. D.; Chew, D. P. Acute myocardial infarction. Lancet, 2008, 372(9638), 570-584.
61. Tousoulis, D.; Siasos, G.; Zaromitidou, M.; Oikonomou, E.; Maniatis, K.; Kioufis, S.; Kokkou, E.; Papavassiliou, A. G.; Stefanadis, C. The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel. Int. J. Cardiol., 2013.
62. Tousoulis, D.; Siasos, G.; Maniatis, K.; Oikonomou, E.; Kioufis, S.; Zaromitidou, M.; Paraskevopoulos, T.; Michalea, S.; Kollia, C.; Miliou, A.; Kokkou, E.; Papavassiliou, A. G.; Stefanadis, C. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. Int. J. Cardiol., 2012.
63. Siasos, G.; Tousoulis, D.; Stefanadis, C. CYP2C19 genotype and cardiovascular events. JAMA, 2012, 307(14), 1483-1484; author reply 1484-1485.
64. Jaffe, A. S.; Ravkilde, J.; Roberts, R.; Naslund, U.; Apple, F. S.; Galvani, M.; Katus, H. It's time for a change to a troponin standard. Circulation, 2000, 102(11), 1216-1220.
65. Siasos, G.; Tousoulis, D.; Kioufis, S.; Oikonomou, E.; Siasou, Z.; Limperi, M.; Papavassiliou, A. G.; Stefanadis, C. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases. Curr. Top. Med. Chem., 2012, 12(10), 1132-1148.
66. Tousoulis, D.; Siasos, G.; Maniatis, K.; Oikonomou, E.; Vlasis, K.; Papavassiliou, A. G.; Stefanadis, C. Novel biomarkers assessing the calcium deposition in coronary artery disease. Curr. Med. Chem., 2012, 19(6), 901-920.
67. Papageorgiou, N.; Tousoulis, D.; Siasos, G.; Stefanadis, C. Is fibrinogen a marker of inflammation in coronary artery disease? Hellenic J. Cardiol., 2010, 51(1), 1-9.
68. Chen, J. F.; Mandel, E. M.; Thomson, J. M.; Wu, Q.; Callis, T. E.; Hammond, S. M.; Conlon, F. L.; Wang, D. Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet., 2006, 38(2), 228-233.
69. Bostjancic, E.; Zidar, N.; Stajner, D.; Glavac, D. MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction. Folia. Biol. (Praha), 2010, 56(1), 27-31.
70. Cheng, Y.; Tan, N.; Yang, J.; Liu, X.; Cao, X.; He, P.; Dong, X.; Qin, S.; Zhang, C. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin. Sci. (Lond), 2010, 119(2), 87-95.
71. Yang, B.; Lin, H.; Xiao, J.; Lu, Y.; Luo, X.; Li, B.; Zhang, Y.; Xu, C.; Bai, Y.; Wang, H.; Chen, G.; Wang, Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med., 2007, 13(4), 486-491.
72. Lu, Y.; Zhang, Y.; Shan, H.; Pan, Z.; Li, X.; Li, B.; Xu, C.; Zhang, B.; Zhang, F.; Dong, D.; Song, W.; Qiao, G.; Yang, B. MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. Cardiovasc. Res., 2009, 84(3), 434-441.
73. Bostjancic, E.; Zidar, N.; Stajer, D.; Glavac, D. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology, 2010, 115(3), 163-169.
74. Widera, C.; Gupta, S. K.; Lorenzen, J. M.; Bang, C.; Bauersachs, J.; Bethmann, K.; Kempf, T.; Wollert, K. C.; Thum, T. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J. Mol. Cell Cardiol., 2011, 51(5), 872-875.
75. Ye, Y.; Perez-Polo, J. R.; Qian, J.; Birnbaum, Y. The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol. Genomics, 2011, 43(10), 534-542.
76. Keyes, K. T.; Xu, J.; Long, B.; Zhang, C.; Hu, Z.; Ye, Y. Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction. Am. J. Physiol. Heart Circ. Physiol., 2010, 298(4), H1198-1208.
77. Mocanu, M. M.; Yellon, D. M. PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? Br. J. Pharmacol., 2007, 150(7), 833-838.
78. Roy, S.; Khanna, S.; Hussain, S. R.; Biswas, S.; Azad, A.; Rink, C.; Gnyawali, S.; Shilo, S.; Nuovo, G. J.; Sen, C. K. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res., 2009, 82(1), 21-29.
79. Zhu, H.; Fan, G. C. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc. Res., 2012, 94(2), 284-292.
80. Wen, Z.; Zheng, S.; Zhou, C.; Yuan, W.; Wang, J.; Wang, T. Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators. J. Cell Mol. Med., 2012, 16(4), 657-671.
81. Small, E. M.; Frost, R. J.; Olson, E. N. MicroRNAs add a new dimension to cardiovascular disease. Circulation, 2010, 121(8), 1022-1032.
82. Alberti, K. G.; Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med., 1998, 15(7), 539-553.
83. Antoniades, C.; Tousoulis, D.; Marinou, K.; Papageorgiou, N.; Bosinakou, E.; Tsioufis, C.; Stefanadi, E.; Latsios, G.; Tentolouris, C.; Siasos, G.; Stefanadis, C. Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis. Clin. Cardiol., 2007, 30(6), 295-300.
84. Siasos, G.; Tousoulis, D.; Oikonomou, E.; Zaromitidou, M.; Stefanadis, C.; Papavassiliou, A. G. Inflammatory markers in hyperlipidemia: from experimental models to clinical practice. Curr. Pharm. Des., 2011, 17(37), 4132-4146.
85. Kampoli, A. M.; Tousoulis, D.; Antoniades, C.; Siasos, G.; Stefanadis, C. Biomarkers of premature atherosclerosis. Trends Mol. Med., 2009, 15(7), 323-332.
86. Najafi-Shoushtari, S. H. MicroRNAs in cardiometabolic disease. Curr. Atheroscler. Rep., 2011, 13(3), 202-207.
87. Shantikumar, S.; Caporali, A.; Emanueli, C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc. Res., 2012, 93(4), 583-593.
88. Poy, M. N.; Eliasson, L.; Krutzfeldt, J.; Kuwajima, S.; Ma, X.; Macdonald, P. E.; Pfeffer, S.; Tuschl, T.; Rajewsky, N.; Rorsman, P.; Stoffel, M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature, 2004, 432(7014), 226-230.
89. Poy, M. N.; Hausser, J.; Trajkovski, M.; Braun, M.; Collins, S.; Rorsman, P.; Zavolan, M.; Stoffel, M. miR-375 maintains normal pancreatic alpha-and beta-cell mass. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(14), 5813-5818.
90. Puigserver, P.; Rodgers, J. T. Foxa2, a novel transcriptional regulator of insulin sensitivity. Nat. Med., 2006, 12(1), 38-39.
91. Zhao, E.; Keller, M. P.; Rabaglia, M. E.; Oler, A. T.; Stapleton, D. S.; Schueler, K. L.; Neto, E. C.; Moon, J. Y.; Wang, P.; Wang, I. M.; Lum, P. Y.; Ivanovska, I.; Cleary, M.; Greenawalt, D.; Tsang, J.; Choi, Y. J.; Kleinhanz, R.; Shang, J.; Zhou, Y. P.; Howard, A. D.; Zhang, B. B.; Kendziorski, C.; Thornberry, N. A.; Yandell, B. S.; Schadt, E. E.; Attie, A. D. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm. Genome, 2009, 20(8), 476-485.
92. Goossens, G. H. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol. Behav., 2008, 94(2), 206-218.
93. He, A.; Zhu, L.; Gupta, N.; Chang, Y.; Fang, F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol., 2007, 21(11), 2785-2794.
94. Ling, H. Y.; Ou, H. S.; Feng, S. D.; Zhang, X. Y.; Tuo, Q. H.; Chen, L. X.; Zhu, B. Y.; Gao, Z. P.; Tang, C. K.; Yin, W. D.; Zhang, L.; Liao, D. F. CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin Exp Pharmacol. Physiol., 2009, 36(9), e32-39.
95. Krishnaswami, A.; Ravi-Kumar, S.; Lewis, J. M. Thiazolidinediones: a 2010 perspective. Perm. J., 2010, 14(3), 64-72.
96. Dickstein, K.; Cohen-Solal, A.; Filippatos, G.; McMurray, J. J.; Ponikowski, P.; Poole-Wilson, P. A.; Stromberg, A.; van Veldhuisen, D. J.; Atar, D.; Hoes, A. W.; Keren, A.; Mebazaa, A.; Nieminen, M.; Priori, S. G.; Swedberg, K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. J. Heart Fail., 2008, 10(10), 933-989.
97. Tousoulis, D.; Oikonomou, E.; Siasos, G.; Chrysohoou, C.; Charakida, M.; Trikas, A.; Siasou, Z.; Limperi, M.; Papadimitriou, E. D.; Papavassiliou, A. G.; Stefanadis, C. Predictive value of biomarkers in patients with heart failure. Curr. Med. Chem., 2012, 19(16), 2534-2547.
98. Oikonomou, E.; Tousoulis, D.; Siasos, G.; Zaromitidou, M.; Papavassiliou, A. G.; Stefanadis, C. The role of inflammation in heart failure: new therapeutic approaches. Hellenic J. Cardiol., 2011, 52(1), 30-40.
99. Oliveira-Carvalho, V.; Silva, M. M.; Guimaraes, G. V.; Bacal, F.; Bocchi, E. A. MicroRNAs: new players in heart failure. Mol. Biol. Rep., 2012.
100. Tousoulis, D.; Oikonomou, E.; Siasos, G.; Chrysohoou, C.; Zaromitidou, M.; Kioufis, S.; Maniatis, K.; Dilaveris, P.; Miliou, A.; Michalea, S.; Papavassiliou, A. G.; Stefanadis, C. Dosedependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure. Atherosclerosis, 2013, 227(2), 367-372.
101. Ikeda, S.; He, A.; Kong, S. W.; Lu, J.; Bejar, R.; Bodyak, N.; Lee, K. H.; Ma, Q.; Kang, P. M.; Golub, T. R.; Pu, W. T. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol. Cell Biol., 2009, 29(8), 2193-2204.
102. Tousoulis, D.; Kampoli, A. M.; Papageorgiou, N.; Antoniades, C.; Siasos, G.; Latsios, G.; Tsiamis, E.; Stefanadis, C. Matrix metallopropteinases in heart failure. Curr. Top. Med. Chem., 2012, 12(10), 1181-1191.
103. Rafiq, S.; Anand, S.; Roberts, R. Genome-wide association studies of hypertension: have they been fruitful? J. Cardiovasc. Transl. Res., 2010, 3(3), 189-196.
104. Stefanadi, E.; Tousoulis, D.; Androulakis, E. S.; Papageorgiou, N.; Charakida, M.; Siasos, G.; Tsioufis, C.; Stefanadis, C. Inflammatory markers in essential hypertension: potential clinical implications. Curr. Vasc. Pharmacol., 2010, 8(4), 509-516.
105. Androulakis, E.; Tousoulis, D.; Papageorgiou, N.; Latsios, G.; Siasos, G.; Stefanadis, C. The role of matrix metalloproteinases in essential hypertension. Curr. Top. Med. Chem., 2012, 12(10), 1149-1158.
106. Siasos, G.; Tousoulis, D.; Michalea, S.; Oikonomou, E.; Kolia, C.; Kioufis, S.; Synetos, A.; Vlasis, K.; Papavassiliou, A. G.; Stefanadis, C. Biomarkers determining cardiovascular risk in patients with kidney disease. Curr. Med. Chem., 2012, 19(16), 2555-2571.
107. Tousoulis, D.; Siasos, G.; Oikonomou, E.; Stougianos, P.; Papageorgiou, N.; Papavassiliou, A. G.; Stefanadis, C. Asymmetric dimethylarginine (ADMA): is really a biomarker for cardiovascular prognosis? Int. J. Cardiol., 2011, 153(2), 123-125.
108. Siasos, G.; Tousoulis, D.; Siasou, Z.; Stefanadis, C.; Papavassiliou, A. G. Shear stress, protein kinases and atherosclerosis. Curr. Med. Chem., 2007, 14(14), 1567-1572.
109. Tousoulis, D.; Antoniades, C.; Vasiliadou, C.; Kourtellaris, P.; Koniari, K.; Marinou, K.; Charakida, M.; Ntarladimas, I.; Siasos, G.; Stefanadis, C. Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the inflammatory process in patients with type 2 diabetes mellitus. Heart, 2007, 93(2), 244-246.
110. Li, S.; Zhu, J.; Zhang, W.; Chen, Y.; Zhang, K.; Popescu, L. M.; Ma, X.; Lau, W. B.; Rong, R.; Yu, X.; Wang, B.; Li, Y.; Xiao, C.; Zhang, M.; Wang, S.; Yu, L.; Chen, A. F.; Yang, X.; Cai, J. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation, 2011, 124(2), 175-184.
111. Schulz, R.; Rassaf, T.; Massion, P. B.; Kelm, M.; Balligand, J. L. Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. Pharmacol. Ther., 2005, 108(3), 225-256.
112. Tousoulis, D.; Boger, R. H.; Antoniades, C.; Siasos, G.; Stefanadi, E.; Stefanadis, C. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective. Nat. Clin. Pract. Cardiovasc. Med., 2007, 4(5), 274-283.
113. Siasos, G.; Tousoulis, D.; Antoniades, C.; Stefanadi, E.; Stefanadis, C. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis? Int. J. Cardiol., 2007, 116(3), 300-308.
114. Martin, M. M.; Lee, E. J.; Buckenberger, J. A.; Schmittgen, T. D.; Elton, T. S. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem., 2006, 281(27), 18277-18284.
115. Berger, S.; Bleich, M.; Schmid, W.; Cole, T. J.; Peters, J.; Watanabe, H.; Kriz, W.; Warth, R.; Greger, R.; Schutz, G. Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc. Natl. Acad. Sci. U. S. A., 1998, 95(16), 9424-9429.
116. Wu, P.; Zuo, X.; Ji, A. Stroke-induced microRNAs: The potential therapeutic role for stroke. Exp. Ther. Med., 2012, 3(4), 571-576.
117. Lloyd-Jones, D.; Adams, R. J.; Brown, T. M.; Carnethon, M.; Dai, S.; De Simone, G.; Ferguson, T. B.; Ford, E.; Furie, K.; Gillespie, C.; Go, A.; Greenlund, K.; Haase, N.; Hailpern, S.; Ho, P. M.; Howard, V.; Kissela, B.; Kittner, S.; Lackland, D.; Lisabeth, L.; Marelli, A.; McDermott, M. M.; Meigs, J.; Mozaffarian, D.; Mussolino, M.; Nichol, G.; Roger, V. L.; Rosamond, W.; Sacco, R.; Sorlie, P.; Thom, T.; Wasserthiel-Smoller, S.; Wong, N. D.; Wylie-Rosett, J. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation, 2010, 121(7), e46-e215.
118. Tan, J. R.; Koo, Y. X.; Kaur, P.; Liu, F.; Armugam, A.; Wong, P. T.; Jeyaseelan, K. microRNAs in stroke pathogenesis. Curr. Mol. Med., 2011, 11(2), 76-92.
119. Boissonneault, V.; Plante, I.; Rivest, S.; Provost, P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J. Biol. Chem., 2009, 284(4), 1971-1981.
120. Yin, K. J.; Deng, Z.; Hamblin, M.; Xiang, Y.; Huang, H.; Zhang, J.; Jiang, X.; Wang, Y.; Chen, Y. E. Peroxisome proliferatoractivated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J. Neurosci., 2010, 30(18), 6398-6408.
121. Rink, C.; Khanna, S. MicroRNA in ischemic stroke etiology and pathology. Physiol. Genomics, 2011, 43(10), 521-528.
122. Tousoulis, D.; Zisimos, K.; Antoniades, C.; Stefanadi, E.; Siasos, G.; Tsioufis, C.; Papageorgiou, N.; Vavouranakis, E.; Vlachopoulos, C.; Stefanadis, C. Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension. Int. J. Cardiol., 2009, 136(3), 258-262.
123. Nattel, S.; Maguy, A.; Le Bouter, S.; Yeh, Y. H. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol. Rev., 2007, 87(2), 425-456.
124. John, R. M.; Tedrow, U. B.; Koplan, B. A.; Albert, C. M.; Epstein, L. M.; Sweeney, M. O.; Miller, A. L.; Michaud, G. F.; Stevenson, W. G. Ventricular arrhythmias and sudden cardiac death. Lancet, 2012, 380(9852), 1520-1529.
125. Farrell, E. F.; Antaramian, A.; Rueda, A.; Gomez, A. M.; Valdivia, H. H. Sorcin inhibits calcium release and modulates excitationcontraction coupling in the heart. J. Biol. Chem., 2003, 278(36), 34660-34666.
126. Fan, G. C.; Yuan, Q.; Kranias, E. G. Regulatory roles of junctin in sarcoplasmic reticulum calcium cycling and myocardial function. Trends Cardiovasc. Med., 2008, 18(1), 1-5.
127. Ono, M.; Yano, M.; Hino, A.; Suetomi, T.; Xu, X.; Susa, T.; Uchinoumi, H.; Tateishi, H.; Oda, T.; Okuda, S.; Doi, M.; Kobayashi, S.; Yamamoto, T.; Koseki, N.; Kyushiki, H.; Ikemoto, N.; Matsuzaki, M. Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure. Cardiovasc. Res., 2010, 87(4), 609-617.
128. Gyorke, S.; Terentyev, D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovasc. Res., 2008, 77(2), 245-255.
129. Elton, T. S.; Martin, M. M.; Sansom, S. E.; Belevych, A. E.; Gyorke, S.; Terentyev, D. miRNAs got rhythm. Life Sci., 2011, 88(9-10), 373-383.
130. Chen, W. J.; Yin, K.; Zhao, G. J.; Fu, Y. C.; Tang, C. K. The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis, 2012, 222(2), 314-323.
131. Chen, W. J.; Zhang, M.; Zhao, G. J.; Fu, Y.; Zhang, D. W.; Zhu, H. B.; Tang, C. K. MicroRNA-33 in atherosclerosis etiology and pathophysiology. Atherosclerosis, 2013, 227(2), 201-208.
132. Rayner, K. J.; Suarez, Y.; Davalos, A.; Parathath, S.; Fitzgerald, M. L.; Tamehiro, N.; Fisher, E. A.; Moore, K. J.; Fernandez-Hernando, C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science, 2010, 328(5985), 1570-1573.
133. Moore, K. J.; Rayner, K. J.; Suarez, Y.; Fernandez-Hernando, C. microRNAs and cholesterol metabolism. Trends Endocrinol. Metab., 2010, 21(12), 699-706.
134. Horie, T.; Ono, K.; Horiguchi, M.; Nishi, H.; Nakamura, T.; Nagao, K.; Kinoshita, M.; Kuwabara, Y.; Marusawa, H.; Iwanaga, Y.; Hasegawa, K.; Yokode, M.; Kimura, T.; Kita, T. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc. Natl. Acad. Sci. U. S.A., 2010, 107(40), 17321-17326.
135. Esau, C.; Davis, S.; Murray, S. F.; Yu, X. X.; Pandey, S. K.; Pear, M.; Watts, L.; Booten, S. L.; Graham, M.; McKay, R.; Subramaniam, A.; Propp, S.; Lollo, B. A.; Freier, S.; Bennett, C. F.; Bhanot, S.; Monia, B. P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab., 2006, 3(2), 87-98.
136. Song, K. H.; Li, T.; Owsley, E.; Chiang, J. Y. A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes. J. Lipid Res., 2010, 51(8), 2223-2233.
137. Chiang, J. Y. Bile acids: regulation of synthesis. J. Lipid Res., 2009, 50(10), 1955-1966.
138. Ramirez, C. M.; Davalos, A.; Goedeke, L.; Salerno, A. G.; Warrier, N.; Cirera-Salinas, D.; Suarez, Y.; Fernandez-Hernando, C. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler. Thromb. Vasc. Biol., 2011, 31(11), 2707-2714.
139. Qin, B.; Yang, H.; Xiao, B. Role of microRNAs in endothelial inflammation and senescence. Mol. Biol. Rep., 2012, 39(4), 4509-4518.
140. Larsen, L.; Rosenstierne, M. W.; Gaarn, L. W.; Bagge, A.; Pedersen, L.; Dahmcke, C. M.; Nielsen, J. H.; Dalgaard, L. T. Expression and localization of microRNAs in perinatal rat pancreas: role of miR-21 in regulation of cholesterol metabolism. PLoS. One, 2011, 6(10), e25997.